Nonetheless, the overlap between GLP-1 side effects and IBS symptoms means we need to look carefully at how these medications might exacerbate or alleviate IBS in different scenarios
doi:10.1111/nmo.12516 Chen B, Kim JJ, Zhang Y, Du L, Dai N
Il conviendra de surveiller lefficacit du traitement en mesurant lacide mthylmalonique dans les urines ou la transcobalamine sanguine en particulier en cas dinsuffisance urinaire
Given their glucose-lowering effects, GLP-1s have become standard of care for type 2 diabetes, supplanting other medication classes such as sulfonylureas.2 In 2023, GLP-1s represented 63% of diabetes spend, up from 38% in 2020.2 While diabetes GLP-1s will continue to account for a greater portion of spend compared to obesity, costs related to GLP-1s prescribed for obesity are expected to grow at a faster rate over the next 3 years
A GLP-1 analogue is a medicine designed to mimic or activate the glucagon-like peptide-1 pathway
But individual responses vary, and regular monitoring confirms your liver is responding well